DRAP has established the National Pharmacovigilance Centre (NPC), under the Division of Pharmacy Services, DRAP, Islamabad, to monitor the therapeutic goods’ safety across the country. NPC has developed different reporting channels that are available through the official website of DRAP and a mobile application (MED Safety) for reporting of any Adverse Events (AE) to ensure the safety of therapeutic goods.
These guidelines details the principle requirements for Adverse Events reporting by Healthcare Professionals and provide guidance on reporting channels available to the Healthcare professionals for AE reporting. HCPs are responsible for the timely identification, documentation, and reporting of AEs and their contribution is essential to the early detection and reporting of an AE. The purpose of this document is to. –
- Guide and enlighten HCPs about reporting AEs to NPC, DRAP;
- To enhance the participation of HCPs in the reporting system of the country; and
- To develop a spontaneous reporting culture in the country to ensure therapeutic good’s safety.
Click to view the guidance document of ADVERSE EVENTS REPORTING GUIDELINES FOR HEALTHCARE PROFESSIONALS